NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR ...
Visit a quote page and your recently viewed tickers will be displayed here.
New preclinical data on PRMT5-MTA inhibitor program will also be presented NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results